SLC22A5 (solute carrier family 22 member 5)

2011-07-01  

Identity

HGNC
LOCATION
5q31.1
LOCUSID
ALIAS
CDSP,OCTN2
FUSION GENES

Other Information

Locus ID:

NCBI: 6584
MIM: 603377
HGNC: 10969
Ensembl: ENSG00000197375

Variants:

dbSNP: 6584
ClinVar: 6584
TCGA: ENSG00000197375
COSMIC: SLC22A5

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000197375ENST00000245407O76082
ENSG00000197375ENST00000415928H7BZC0
ENSG00000197375ENST00000435065O76082
ENSG00000197375ENST00000437841F8WCC9
ENSG00000197375ENST00000447841H7BZF0
ENSG00000197375ENST00000448810H7C1R8

Expression (GTEx)

0
10
20
30
40
50
60

Pathways

PathwaySourceExternal ID
Choline metabolism in cancerKEGGhsa05231
Choline metabolism in cancerKEGGko05231
Transmembrane transport of small moleculesREACTOMER-HSA-382551
SLC-mediated transmembrane transportREACTOMER-HSA-425407
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsREACTOMER-HSA-425366
Organic cation/anion/zwitterion transportREACTOMER-HSA-549132
Organic cation transportREACTOMER-HSA-549127

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA10804imatinibChemicalClinicalAnnotation, VariantAnnotationassociatedPD23127916, 28762371
PA151958383Gastrointestinal Stromal TumorsDiseaseClinicalAnnotation, VariantAnnotationassociatedPD23127916, 28762371
PA166176782periorbital edemaDiseaseVariantAnnotationassociatedPD28762371

References

Pubmed IDYearTitleCitations
365395622023Evaluation of the gene encoding carnitine transporter (OCTN2/SLC22A5) expression in human breast cancer and its association with clinicopathological characteristics.0
371874222023The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase.0
365395622023Evaluation of the gene encoding carnitine transporter (OCTN2/SLC22A5) expression in human breast cancer and its association with clinicopathological characteristics.0
371874222023The activity and surface presence of organic cation/carnitine transporter OCTN2 (SLC22A5) in breast cancer cells depends on AKT kinase.0
363432602022Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency.8
363432602022Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency.8
326541402021Glioma cells survival depends both on fatty acid oxidation and on functional carnitine transport by SLC22A5.21
329643102021Tooth loss and adiposity: possible role of carnitine transporter (OCTN1/2) polymorphisms in women but not in men.1
333348772021Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2).5
347044122021Screening and follow-up results of fatty acid oxidative metabolism disorders in 608 818 newborns in Jining, Shandong province.4
347297412021[Analysis of metabolic profile and genetic variants for newborns with primary carnitine deficiency from Guangxi].2
326541402021Glioma cells survival depends both on fatty acid oxidation and on functional carnitine transport by SLC22A5.21
329643102021Tooth loss and adiposity: possible role of carnitine transporter (OCTN1/2) polymorphisms in women but not in men.1
333348772021Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2).5
347044122021Screening and follow-up results of fatty acid oxidative metabolism disorders in 608 818 newborns in Jining, Shandong province.4

Citation

Dessen P

SLC22A5 (solute carrier family 22 member 5)

Atlas Genet Cytogenet Oncol Haematol. 2011-07-01

Online version: http://atlasgeneticsoncology.org/gene/52518/slc22a5